NO993928D0 - Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium - Google Patents
Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammoniumInfo
- Publication number
- NO993928D0 NO993928D0 NO993928A NO993928A NO993928D0 NO 993928 D0 NO993928 D0 NO 993928D0 NO 993928 A NO993928 A NO 993928A NO 993928 A NO993928 A NO 993928A NO 993928 D0 NO993928 D0 NO 993928D0
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- quaternary ammonium
- oral administration
- heterocyclic compounds
- heterocyclic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9701825A FR2759584B1 (en) | 1997-02-17 | 1997-02-17 | PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF HETEROCYCLIC COMPOUNDS IN QUATERNARY AMMONIUM FORM |
PCT/FR1998/000298 WO1998035662A1 (en) | 1997-02-17 | 1998-02-17 | Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993928D0 true NO993928D0 (en) | 1999-08-16 |
NO993928L NO993928L (en) | 1999-08-16 |
Family
ID=9503804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993928A NO993928L (en) | 1997-02-17 | 1999-08-16 | Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0969825A1 (en) |
JP (1) | JP2001511795A (en) |
AR (1) | AR011805A1 (en) |
AU (1) | AU6404998A (en) |
BR (1) | BR9807694A (en) |
CA (1) | CA2281560A1 (en) |
FR (1) | FR2759584B1 (en) |
HR (1) | HRP980075A2 (en) |
NO (1) | NO993928L (en) |
WO (1) | WO1998035662A1 (en) |
ZA (1) | ZA981289B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102188424B (en) * | 2011-03-23 | 2013-03-27 | 浙江理工大学 | Anti-leukemia effects of SR140333 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2676054B1 (en) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | NOVEL N-ALKYLENEPIPERIDINO COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
FR2676055B1 (en) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | AMINO POLYCYCLIC COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
FR2688219B1 (en) * | 1992-03-03 | 1994-07-08 | Sanofi Elf | AMATONIUM QUATERNARY SALTS OF AMINO AROMATIC COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
FR2696178B1 (en) * | 1992-09-30 | 1994-12-30 | Sanofi Elf | Quaternary basic amides, process for their preparation and pharmaceutical compositions containing them. |
FR2717804B1 (en) * | 1994-03-25 | 1996-06-21 | Sanofi Sa | Salts of substituted nitrogen heteroaromatic compounds, process for their preparation and pharmaceutical compositions containing them. |
EP0777666B1 (en) * | 1994-08-25 | 1999-03-03 | Merrell Pharmaceuticals Inc. | Substituted piperidines useful for the treatment of allergic diseases |
FR2725986B1 (en) * | 1994-10-21 | 1996-11-29 | Adir | NOVEL PIPERIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2725900B1 (en) * | 1994-10-21 | 1997-07-18 | Sanofi Sa | USE OF NK1 RECEPTOR ANTAGONISTS FOR THE PREPARATION OF DRUGS WITH CARDIOREGULATORY ACTION |
FR2729951B1 (en) * | 1995-01-30 | 1997-04-18 | Sanofi Sa | NOVEL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
FR2729954B1 (en) * | 1995-01-30 | 1997-08-01 | Sanofi Sa | SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
1997
- 1997-02-17 FR FR9701825A patent/FR2759584B1/en not_active Expired - Fee Related
-
1998
- 1998-02-16 HR HR9701825A patent/HRP980075A2/en not_active Application Discontinuation
- 1998-02-16 AR ARP980100675A patent/AR011805A1/en unknown
- 1998-02-17 ZA ZA981289A patent/ZA981289B/en unknown
- 1998-02-17 JP JP53543298A patent/JP2001511795A/en active Pending
- 1998-02-17 WO PCT/FR1998/000298 patent/WO1998035662A1/en not_active Application Discontinuation
- 1998-02-17 BR BR9807694A patent/BR9807694A/en not_active Application Discontinuation
- 1998-02-17 EP EP98909549A patent/EP0969825A1/en not_active Withdrawn
- 1998-02-17 AU AU64049/98A patent/AU6404998A/en not_active Abandoned
- 1998-02-17 CA CA002281560A patent/CA2281560A1/en not_active Abandoned
-
1999
- 1999-08-16 NO NO993928A patent/NO993928L/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR9807694A (en) | 2000-03-21 |
EP0969825A1 (en) | 2000-01-12 |
ZA981289B (en) | 1998-08-26 |
HRP980075A2 (en) | 1998-10-31 |
FR2759584B1 (en) | 1999-06-11 |
AU6404998A (en) | 1998-09-08 |
WO1998035662A1 (en) | 1998-08-20 |
CA2281560A1 (en) | 1998-08-20 |
AR011805A1 (en) | 2000-09-13 |
JP2001511795A (en) | 2001-08-14 |
FR2759584A1 (en) | 1998-08-21 |
NO993928L (en) | 1999-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE04578B1 (en) | Pharmaceutical composition for oral administration of the N-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates | |
NO995809L (en) | Pharmaceutical formulation of omeprazole | |
DK0876131T3 (en) | Compositions for drug administration for improved stability of androgens | |
NO973479L (en) | Substituted heterocyclic compounds, method of preparation and pharmaceutical compositions containing the same | |
DE69634053D1 (en) | Oral drug composition containing 2-methyl-thienobenzodiazepine | |
NO994757D0 (en) | Procedure for Oral Administration of Proteins | |
EE9700241A (en) | Pharmaceutical composition for transdermal administration | |
NO996372D0 (en) | Solid pharmaceutical preparation containing benzofuan derivatives | |
EE03177B1 (en) | Heterobicyclic compounds, methods for their preparation and pharmaceutical compositions containing said compounds | |
NO973938L (en) | Pharmaceutical preparation of piperidinoalkanol compounds | |
NO20012248D0 (en) | Pharmaceutical preparation of moxifloxacin | |
NO953367L (en) | Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as drugs | |
NO20041007L (en) | Use of oxypurine nucleosides for the preparation of a pharmaceutical composition | |
EE200000226A (en) | 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition | |
BR9610530A (en) | Heteroaryl substituted acryloylguanidine derivatives and pharmaceutical compositions containing the same | |
NO308236B1 (en) | Pharmaceutical composition containing indole derivatives | |
NO20001717D0 (en) | Serotonin-containing formulation for oral administration and use of the same | |
EE9900206A (en) | Pharmaceutical compositions containing N-sulfonylindoline derivatives | |
NO975680L (en) | Oral pharmaceutical preparation of piperidinoalkanol compounds in solution form | |
FR2759585B1 (en) | PHARMACEUTICAL FORMULATIONS PRESENTED IN A DRY FORM FOR THE ORAL ADMINISTRATION OF A CYCLIC QUATERNARY AMMONIUM COMPOUND | |
BR9607433A (en) | Pharmaceutical composition for parental administration | |
EE04095B1 (en) | Use of ketolides and pharmaceutically acceptable salts thereof for the preparation of pharmaceutical compositions | |
NO993928D0 (en) | Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium | |
NO20003393D0 (en) | Process for the preparation of a pharmaceutical formulation | |
ITMI913510A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH BIOAVAILABILITY PROGESTERONE |